Legato Capital Management LLC
Position in HRMY — Harmony Biosciences Holdings, Inc.
CIK 1442641
San Francisco, CA
Position in HRMY
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$779,501
-$208,050 QoQ
Shares Held
21,409
-18.9% QoQ
Ownership
0.037%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#155
of 319 holders
Holding Since
Jun 2023
8 quarters on record
Common Shares in HRMY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Legato Capital Management LLC holds $23,431,924 across 9 Biotechnology names. HRMY ranks #8 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MIRM |
Mirum Pharmaceuticals, Inc.
|
58,512 | $6,849,999 | |
| 2 | PVLA |
Palvella Therapeutics, Inc.
|
23,490 | $3,589,741 | |
| 3 | CORT |
Corcept Therapeutics Inc
|
41,186 | $3,581,122 | |
| 4 | KRYS |
Krystal Biotech, Inc.
|
8,713 | $3,238,360 | |
| 5 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
26,046 | $2,538,964 | |
| 6 | INSM |
INSMED Inc
|
11,129 | $1,186,573 | |
| 7 | KYMR |
Kymera Therapeutics, Inc.
|
8,354 | $957,953 | |
| 8 | HRMY |
Harmony Biosciences Holdings, Inc.
This page
|
21,409 | $779,501 |
All Filings in HRMY
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $779,501 | 21,409 | Shares | Other | 2026-08-06 | |
| 2025-12-31 | $987,551 | 26,391 | Shares | Other | 2026-02-06 | |
| 2025-09-30 | $1,416,997 | 51,415 | Shares | Other | 2025-11-12 | |
| 2025-06-30 | $1,008,387 | 31,911 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $1,059,126 | 31,911 | Shares | Other | 2025-05-06 | |
| 2024-12-31 | $919,435 | 26,720 | Shares | Other | 2025-01-29 | |
| 2024-09-30 | $848,560 | 21,214 | Shares | Other | 2024-11-07 | |
| 2023-06-30 | $206,565 | 5,870 | Shares | Other | 2023-08-18 | |
| No filing history on record for this holder in this stock. | ||||||